We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves New Labeling for Sanofi Pasteur’s High-Dose Flu Vaccine
FDA Approves New Labeling for Sanofi Pasteur’s High-Dose Flu Vaccine
The FDA has cleared new prescribing information for Sanofi Pasteur’s Fluzone High-Dose influenza vaccine, indicating it provides improved protection for adults 65 years and older.